Home NDC 16714-780 ezetimibe and simvastatin
Product NDC 16714-780
11-digit product format 167140780
Labeler code 16714
Product ID 16714-780_0d1ac067-fb51-46db-98da-5efd6a65e9e1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ezetimibe and simvastatin
Dosage form TABLET
Route ORAL
Labeler NORTHSTAR RX LLC
Application ANDA208699
Marketing category ANDA
Marketing start 2019-08-19
Marketing end 2026-10-31
Substance EZETIMIBE; SIMVASTATIN
Active strength 10; 40 mg/1; mg/1
Pharmacologic classes Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208699-001 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 A208699-002 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 A208699-003 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 A208699-004 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208699-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2019-06-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208699-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2019-06-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208699-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2019-06-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208699-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2019-06-27 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 172 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base ezetimibe and simvastatin Active Ingredients# Ingredient, Strength table Ingredient Strength EZETIMIBE 10 mg/1 SIMVASTATIN 40 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination AGG2FN16EV Internal UNII lookup EOR26LQQ24 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 476345 Internal RxNorm lookup 476349 Internal RxNorm lookup 476350 Internal RxNorm lookup 476351 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 16714-780-01 ezetimibe and simvastatin 30 in 1 BOTTLE TABLET 30 7 16714-780-02 ezetimibe and simvastatin 90 in 1 BOTTLE TABLET 90 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 16714-780 EZETIMIBE AND SIMVASTATIN TABLET [NORTHSTAR RX LLC] 7 Current NDC, Legacy NDC, 2 package rows 20240928_52a46269-2262-4052-a3ff-5455523f591f.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 16714-780-01 16714078001 30 TABLET in 1 BOTTLE (16714-780-01) 30 tablet 2019-08-19 0000-00-00 No No Current 16714-780-02 16714078002 90 TABLET in 1 BOTTLE (16714-780-02) 90 tablet 2019-08-19 0000-00-00 No No Current